BioCentury | Jul 23, 2012
Product Development

Debio's dual deal

...are preclinical. The June deal with Ascepion gives Debiopharm exclusive, worldwide rights to Debio 1144 (formerly ASP-08126...
...and Ascepion in 2010 after the Chinese biotech had compiled a sufficient data package for Debio 1144...
...the University of Guelph and the University of Liverpool . According to Jiang, Ascepion discovered ASP-08126...
BioCentury | Jun 25, 2012
Company News

Ascepion, Debiopharm deal

...Ascepion granted Debiopharm exclusive, worldwide rights to develop and commercialize Debio 1144 (formerly ASP-08126 ). The oral...
BioCentury | Jun 19, 2012
Company News

Debiopharm, Ascepion in cancer deal

...China) granted Debiopharm Group (Lausanne, Switzerland) exclusive, worldwide rights to develop and commercialize Debio 1144 (formerly ASP-08126...
Items per page:
1 - 3 of 3